KOD
Price
$3.28
Change
+$0.10 (+3.14%)
Updated
Apr 26, 6:59 PM EST
16 days until earnings call
STOK
Price
$12.41
Change
+$0.72 (+6.16%)
Updated
Apr 26, 6:59 PM EST
10 days until earnings call
Ad is loading...

Compare trend and price KOD vs STOK

Header iconKOD vs STOK Comparison
Open Charts KOD vs STOKBanner chart's image
Kodiak Sciences
Price$3.28
Change+$0.10 (+3.14%)
Volume$154.37K
CapitalizationN/A
Stoke Therapeutics
Price$12.41
Change+$0.72 (+6.16%)
Volume$410.21K
CapitalizationN/A
View a ticker or compare two or three
KOD vs STOK Comparison Chart

Loading...

KODDaily Signal changed days agoGain/Loss if shorted
 
Show more...
STOKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
KOD vs. STOK commentary
Apr 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a StrongSell and STOK is a StrongBuy.

COMPARISON
Comparison
Apr 27, 2024
Stock price -- (KOD: $3.28 vs. STOK: $12.41)
Brand notoriety: KOD and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 30% vs. STOK: 57%
Market capitalization -- KOD: $172.31M vs. STOK: $646.78M
KOD [@Biotechnology] is valued at $172.31M. STOK’s [@Biotechnology] market capitalization is $646.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $556.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 1 FA rating(s) are green whileSTOK’s FA Score has 0 green FA rating(s).

  • KOD’s FA Score: 1 green, 4 red.
  • STOK’s FA Score: 0 green, 5 red.
According to our system of comparison, both KOD and STOK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 4 TA indicator(s) are bullish while STOK’s TA Score has 5 bullish TA indicator(s).

  • KOD’s TA Score: 4 bullish, 6 bearish.
  • STOK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, STOK is a better buy in the short-term than KOD.

Price Growth

KOD (@Biotechnology) experienced а -2.38% price change this week, while STOK (@Biotechnology) price change was +2.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.69%. For the same industry, the average monthly price growth was -8.16%, and the average quarterly price growth was +1262.42%.

Reported Earning Dates

KOD is expected to report earnings on Aug 12, 2024.

STOK is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Biotechnology (+1.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for KOD with price predictions.
OPEN
A.I.dvisor published
a Summary for STOK with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
STOK($647M) has a higher market cap than KOD($172M). STOK YTD gains are higher at: 135.932 vs. KOD (7.895).
KODSTOKKOD / STOK
Capitalization172M647M27%
EBITDAN/AN/A-
Gain YTD7.895135.9326%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
KODSTOK
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 17 days ago
87%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 9 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
KODDaily Signal changed days agoGain/Loss if shorted
 
Show more...
STOKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ADCIX26.490.48
+1.85%
American Century Disciplined Growth I
SROIX11.530.16
+1.41%
Calamos Antetokounmpo Sustainable Eqs I
OPOCX91.210.56
+0.62%
Invesco Discovery A
CRRYX17.790.11
+0.62%
Columbia Small Cap Value II Inst3
JVSCX14.760.09
+0.61%
Janus Henderson Small-Mid Cap Value C

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with NTLA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+2.98%
NTLA - KOD
40%
Loosely correlated
+3.70%
STOK - KOD
40%
Loosely correlated
+6.16%
NUVB - KOD
40%
Loosely correlated
+2.29%
INZY - KOD
37%
Loosely correlated
+2.54%
CMPX - KOD
36%
Loosely correlated
-2.03%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with NUVB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
+6.16%
NUVB - STOK
50%
Loosely correlated
+2.29%
QTTB - STOK
44%
Loosely correlated
-0.78%
INZY - STOK
44%
Loosely correlated
+2.54%
STRO - STOK
43%
Loosely correlated
N/A
KOD - STOK
40%
Loosely correlated
+2.98%
More